The Supreme Court has temporarily extended access to mifepristone, a widely used abortion pill, allowing for continued telehealth services and mail-order prescriptions as deliberations on its legal status continue. This decision comes amidst various challenges and calls for restrictions on the distribution of the medication, particularly from states like Louisiana, which are urging the Court to block mail access. Advocates for abortion rights express concern that the ongoing legal battles could undermine healthcare access. As the Court mulls these significant rulings, the implications for women’s reproductive rights remain uncertain.